Evidence map›Paper›PMID 31300682›Full record

ArticleScientific reports2019

Circulating CXCR3

Jian Zhang, Wenpei Liu, Bo Wen, Ting Xie, Ping Tang, Yabin Hu, Liyan Huang, Kun Jin, Ping Zhang, Ziyan Liu and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. TIGITFrontiers in immunology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. SARS-CoV-2 spike-specific TSignal transduction and targeted therapy · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jian ZhangTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan, 423000, China.ORCID http://orcid.org/0000-0002-5982-419X
Wenpei LiuTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan, 423000, China.
Bo WenTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan, 423000, China.
Ting XieTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan, 423000, China.
Ping TangTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan, 423000, China.
Yabin HuTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan, 423000, China.
Liyan HuangTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan, 423000, China.
Kun JinTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan, 423000, China.
Ping ZhangTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan, 423000, China.
Ziyan LiuTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan, 423000, China.
Ling NiuTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan, 423000, China.
Xiaowang QuTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan, 423000, China. quxiaowang@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating T follicular helper (cTfh) cells have been identified as counterparts of germinal center Tfh (GC Tfh) cells in humans and can support T-dependent B cell maturation and antibody production in vitro. However, the role of cTfh cells in neutralizing antibody (nAb) responses in HCV infection remains unclear. Here, we characterized the phenotype and function of cTfh cells and demonstrated the associations of cTfh cells and their subsets with nAb responses in HCV infection. A total of 38 HCV-infected individuals and 28 healthy controls were enrolled from a pool of injection drug users. The frequency and function of blood Tfh cells were analyzed by flow cytometry. The titers and breadths of serum nAbs were measured using HCV pseudo-particle neutralization assays. Herein, we report several key observations. First, HCV infection skewed cTfh toward CXCR3

Indexed as

AdultAntibodies, NeutralizingAntibodies, ViralCell DifferentiationCell LineFemaleGerminal CenterHEK293 CellsHepacivirusHepatitis CHumansLymphocyte ActivationMaleMiddle AgedReceptors, CXCR3Thyroid Epithelial CellsAntibodies, NeutralizingAntibodies, ViralCXCR3 protein, humanReceptors, CXCR3

Identifiers

PMID31300682
PMCPMC6626020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.